Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

REVEALED: Here s what to expect from gilead sciences next earnings report | Vintage Vibes

Gilead Sciences, Inc. (GILD), based in Foster City, California, is a leading biopharmaceutical company focused on developing and commercializing groundbreaking therapies for diseases like HIV, liver conditions, cancer, and inflammation. Its market cap currently stands at $129 billion. 

Gilead is poised to release its fiscal Q1 earnings results after the market closes on Thursday, Apr. 24. Ahead of the event, analysts expect GILD to report a profit of $1.73 per share, up 231.1% from the loss of $1.32 per share in the year-ago quarter. The company surpassed Wall Street’s bottom-line estimates in each of the past four quarters, which is impressive.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.